AGA Clinical Practice Update on Functional Heartburn: Expert Review.
暂无分享,去创建一个
C. Gyawali | R. Fass | F. Zerbib | C. Gyawali
[1] J. Pandolfino,et al. Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[2] E. Savarino,et al. Mean Nocturnal Baseline Impedance Correlates with Symptom Outcome When Acid Exposure Time is Inconclusive on Esophageal Reflux Monitoring. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[3] C. Gyawali,et al. High-resolution Manometry can Characterize Esophagogastric Junction Morphology and Predict Esophageal Reflux Burden , 2020, Journal of clinical gastroenterology.
[4] Grant D. Huang,et al. Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn. , 2019, The New England journal of medicine.
[5] S. Horgan,et al. Clinical Presentation of Gastroesophageal Reflux Disease: A Prospective Study on Symptom Diversity and Modification of Questionnaire Application , 2019, Digestive Diseases.
[6] E. Savarino,et al. Esophageal mucosal innervation in functional heartburn: Closer to healthy asymptomatic subjects than to non‐erosive reflux disease patients , 2019, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[7] R. Fass,et al. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] J. Tack,et al. Relations between food intake, psychological distress, and gastrointestinal symptoms: A diary study , 2019, United European gastroenterology journal.
[9] R. Fass,et al. Overlap Between GERD and Functional Esophageal Disorders—a Pivotal Mechanism for Treatment Failure , 2019, Current Treatment Options in Gastroenterology.
[10] A. Hungin,et al. Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD , 2018, The American Journal of Gastroenterology.
[11] R. Penagini,et al. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non‐erosive reflux disease , 2018, Alimentary pharmacology & therapeutics.
[12] W. Whitehead,et al. Oesophageal symptoms are common and associated with other functional gastrointestinal disorders (FGIDs) in an English-speaking Western population , 2018, United European gastroenterology journal.
[13] C. Gyawali,et al. Chronic Cough Is Associated With Long Breaks in Esophageal Peristaltic Integrity on High-resolution Manometry , 2018, Journal of neurogastroenterology and motility.
[14] S. Callegari-Jacques,et al. Juice Test for Identification of Nonerosive Reflux Disease in Heartburn Patients , 2018, Journal of neurogastroenterology and motility.
[15] Minhu Chen,et al. The Rome IV versus Rome III criteria for heartburn diagnosis: A comparative study , 2018, United European gastroenterology journal.
[16] E. Savarino,et al. Modern diagnosis of GERD: the Lyon Consensus , 2018, Gut.
[17] D. Drossman,et al. Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report. , 2017, Gastroenterology.
[18] R. Fass,et al. Reflux Hypersensitivity: A New Functional Esophageal Disorder , 2017, Journal of neurogastroenterology and motility.
[19] J. Pandolfino,et al. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease. , 2017, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[20] C. Gyawali,et al. Management of Gastroesophageal Reflux Disease. , 2017, Gastroenterology.
[21] C. Schleck,et al. Multiple functional gastrointestinal disorders linked to gastroesophageal reflux and somatization: A population‐based study , 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[22] S. Roman,et al. A study with pharyngeal and esophageal 24‐hour pH–impedance monitoring in patients with laryngopharyngeal symptoms refractory to proton pump inhibitors , 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[23] E. Savarino,et al. Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD , 2016, The American Journal of Gastroenterology.
[24] A. Leasure,et al. Comparison of Rectal and Esophageal Sensitivity in Women With Functional Heartburn , 2016, Gastroenterology Nursing.
[25] J. Pandolfino,et al. Feasibility and acceptability of esophageal-directed hypnotherapy for functional heartburn. , 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[26] A. Bredenoord,et al. Esophageal acid sensitivity and mucosal integrity in patients with functional heartburn , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[27] J. Dent,et al. Sleep disturbance due to heartburn and regurgitation is common in patients with functional dyspepsia , 2016, United European gastroenterology journal.
[28] J. Pandolfino,et al. Functional Esophageal Disorders. , 2016, Gastroenterology.
[29] N. Pausawasdi,et al. Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn: A Randomized Placebo-Controlled Trial , 2016, The American Journal of Gastroenterology.
[30] A. Bredenoord,et al. Patients with refractory reflux symptoms often do not have GERD , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[31] E. Savarino,et al. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[32] R. Penagini,et al. Inconsistency in the Diagnosis of Functional Heartburn: Usefulness of Prolonged Wireless pH Monitoring in Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease , 2015, Journal of neurogastroenterology and motility.
[33] P J Kahrilas,et al. The Chicago Classification of esophageal motility disorders, v3.0 , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[34] A. Smout,et al. Systematic review: questionnaires for assessment of gastroesophageal reflux disease. , 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[35] D. Consonni,et al. Usefulness of low- and high-volume multiple rapid swallowing during high-resolution manometry. , 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[36] R. Fass,et al. The role of pain modulators in esophageal disorders – no pain no gain , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[37] Mohammad R. Ostovaneh,et al. Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: Double‐blind placebo‐controlled trial , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[38] M. Aloysius,et al. The effect of melatonin in functional heartburn: A randomized, placebo-controlled clinical trial , 2014 .
[39] E. Savarino,et al. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[40] S. Roman,et al. The Chicago classification for achalasia in a French multicentric cohort. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[41] E. Savarino,et al. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? , 2012, World journal of gastroenterology.
[42] G. Boeckxstaens,et al. Baclofen improves symptoms and reduces postprandial flow events in patients with rumination and supragastric belching. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[43] M. Vaezi,et al. Significance and degree of reflux in patients with primary extraesophageal symptoms , 2011, The Laryngoscope.
[44] S. B. des Varannes,et al. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease , 2011, Gut.
[45] M. Sugiyama,et al. Long-term outcomes of combination of endoscopic submucosal dissection and laparoscopic lymph node dissection without gastrectomy for early gastric cancer patients who have a potential risk of lymph node metastasis. , 2011, Gastrointestinal endoscopy.
[46] E. Savarino,et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[47] M. Fox,et al. Failure to respond to physiologic challenge characterizes esophageal motility in erosive gastro‐esophageal reflux disease , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[48] D. García-Compeán,et al. Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: A prospective study. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[49] V. Garrigues,et al. High Prevalence of Heartburn and Low Acid Sensitivity in Patients with Idiopathic Achalasia , 2011, Digestive Diseases and Sciences.
[50] U. Schöning,et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study , 2010, Gut.
[51] T. Ang,et al. To Bravo or not? A comparison of wireless esophageal pH monitoring and conventional pH catheter to evaluate non‐erosive gastroesophageal reflux disease in a multiracial Asian cohort , 2010, Journal of digestive diseases.
[52] J. Dent,et al. Development of the GerdQ, a tool for the diagnosis and management of gastro‐oesophageal reflux disease in primary care , 2009, Alimentary pharmacology & therapeutics.
[53] E. Savarino,et al. Reflux patterns in patients with short‐segment Barrett’s oesophagus: a study using impedance‐pH monitoring off and on proton pump inhibitor therapy , 2009, Alimentary pharmacology & therapeutics.
[54] M. Vaezi,et al. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[55] L. Chan,et al. Obesity and Gastroesophageal Reflux: Quantifying the Association Between Body Mass Index, Esophageal Acid Exposure, and Lower Esophageal Sphincter Status in a Large Series of Patients with Reflux Symptoms , 2009, Journal of Gastrointestinal Surgery.
[56] Koji Arizono,et al. Why Public Health Agencies Cannot Depend on Good Laboratory Practices as a Criterion for Selecting Data: The Case of Bisphenol A , 2008, Environmental health perspectives.
[57] A. Bredenoord,et al. Esophageal pH-Impedance Monitoring in Patients With Therapy-Resistant Reflux Symptoms: ‘On’ or ‘Off’ Proton Pump Inhibitor? , 2008, The American Journal of Gastroenterology.
[58] W. Chey,et al. The influence of co‐morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro‐oesophageal reflux disease , 2008, Alimentary pharmacology & therapeutics.
[59] B. Naliboff,et al. The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. , 2008, Gastroenterology.
[60] S. Quan,et al. Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. , 2007, Gastroenterology.
[61] R. Fass,et al. Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn , 2007, Alimentary pharmacology & therapeutics.
[62] J. Richter,et al. ACG Practice Guidelines: Esophageal Reflux Testing , 2007, The American Journal of Gastroenterology.
[63] D. O. Castell,et al. Combined multichannel intraluminal impedance–pH monitoring to select patients with persistent gastro‐oesophageal reflux for laparoscopic Nissen fundoplication , 2006, The British journal of surgery.
[64] S. Roman,et al. Ambulatory 24‐h oesophageal impedance–pH recordings: reliability of automatic analysis for gastro‐oesophageal reflux assessment , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[65] P. Miner,et al. Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[66] P. Miner,et al. A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn , 2004, Alimentary pharmacology & therapeutics.
[67] L. Swanström,et al. Outcomes of antireflux surgery in patients with normal preoperative 24-hour pH test results. , 2004, American journal of surgery.
[68] J. Peters,et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication , 1998, Journal of Gastrointestinal Surgery.
[69] G. Domingues,et al. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes. , 2011, Arquivos de gastroenterologia.
[70] R. Fass,et al. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. , 2010, Gastrointestinal endoscopy.